Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?

• Annelieke Pasma ,

  * E-mail: a.pasma@erasmusmc.nl

  Affiliations Department of Rheumatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands, Department of Psychiatry, section Medical Psychology and Psychotherapy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

  ⨯
• Charlotte Schenk,

  Affiliation Department of Rheumatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

  ⨯
• Reinier Timman,

  Affiliation Department of Psychiatry, section Medical Psychology and Psychotherapy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

  ⨯
• Adriaan van ‘t Spijker,

  Affiliation Department of Psychiatry, section Medical Psychology and Psychotherapy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

  ⨯
• Cathelijne Appels,

  Affiliation Department of Rheumatology, Amphia hospital, Breda, the Netherlands

  ⨯
• Willemijn H. van der Laan,

  Affiliation Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands

  ⨯
• Bart van den Bemt,

  Affiliation Department of Pharmacy, Sint Maartenskliniek, Nijmegen, the Netherlands

  ⨯
• Robert Goekoop,

  Affiliation Department of Rheumatology, Haga hospital, the Hague, the Netherlands

  ⨯
• Johanna M. W. Hazes,

  Affiliation Department of Rheumatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

  ⨯
• Jan J. V. Busschbach

  Affiliation Department of Psychiatry, section Medical Psychology and Psychotherapy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

  ⨯